The combination of exercise training and α-lipoic acid treatment has therapeutic effects on the pathogenic phenotypes of Alzheimer's disease in NSE/APPsw-transgenic mice

International Journal of Molecular Medicine

Volumn 25, Issue 3, 2010, Pages 337-346

  Cho, Joon Y ^a   Um, Hyun S ^a   Kang, Eun B ^a   Cho, In H ^a   Kim, Chul H ^a   Cho, Jung S ^b   Hwang, Dae Y ^c  

^a Korea National Sport University   (South Korea)

^b Hoseo University   (South Korea)

^c Pusan National University   (South Korea)

Author keywords

lipoic acid; Alzheimer's disease; Brain derived neurotrophic factor; Exercise training; Glucose transporter 1

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; BRAIN DERIVED NEUROTROPHIC FACTOR; CASPASE 3; CATALASE; CHOLESTEROL; COPPER ZINC SUPEROXIDE DISMUTASE; GLUCOSE; GLUCOSE TRANSPORTER 1; HEAT SHOCK PROTEIN 70; INSULIN; PROTEIN BAX; THIOCTIC ACID;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN LEVEL; CHOLESTEROL BLOOD LEVEL; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; LEARNING; MAZE TEST; MEMORY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SITTING; SPATIAL LEARNING; TRANSGENIC MOUSE; TREADMILL EXERCISE; WATER MAZE TEST;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; ANTIOXIDANTS; BCL-2-ASSOCIATED X PROTEIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CASPASE 3; CATALASE; CATS; EXERCISE THERAPY; GLUCOSE TRANSPORTER TYPE 1; HSP70 HEAT-SHOCK PROTEINS; HUMANS; MEMORY; MICE; MICE, TRANSGENIC; NEUROPSYCHOLOGICAL TESTS; PHOSPHOPYRUVATE HYDRATASE; PHYSICAL CONDITIONING, ANIMAL; PROTO-ONCOGENE PROTEINS C-BCL-2; SUPEROXIDE DISMUTASE; THIOCTIC ACID;

EID: 76949097532     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000350     Document Type: Article

References (50)

1. Boland B and Campbell V: Beta-amyloid (1-40)-induced apoptosis of cultured cortical neurones involves calpain-mediated cleavage of poly-ADP-ribose polymerase. Neurobiol Aging 24: 179-186, 2003.
2. McGrath LT, McGleenon BM, Brennan S, McColl D, McILroy S and Passmore AP: Increased oxidative stress in Alzheimer's disease as assessed with 4-hydroxynonenal but not malondialdehyde. QJM 94: 485-490, 2001.
3. Monji A, Utsumi H, Ueda T, Imoto T, Yoshida I, Hashioka S, Tashiro K and Tashiro N: The relationship between the aggregational state of the amyloid-beta peptides and free radical generation by the peptides. J Neurochem 77: 1425-1432, 2001.
4. Gibson MS, Clarke EE, Zheng H, Van Der Ploeg LH, Ruffolo SC, Thornberry NA, Xanthoudakis S, Zamboni RJ, Roy S and Nicholson DW: Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precusor protein and amyloidogenic A beta peptide formation. Cell 97: 395-406, 1999.
5. Fahnestock M, Garzon D, Holsinger RM and Michalski B: Neurotrophic factors and Alzheimer's disease: are we focusing on the wrong molecule? J Neural Transm 62: 241-252, 2002.
6. Lesne S, Gabriel C, Nelson DA, White E, Mackenzie ET, Vivien D and Buisson A: Akt-dependent expression of NAIP-1 protects neurons against amyloid-{beta} toxicity. J Biol Chem 280: 24941-24947, 2005.
7. Hooijmans CR, Graven C, Dederen PJ, Tanila H, van Groen T and Kiliaan AJ: Amyloid beta deposition is related to decreased glucose transporter-1 levels and hippocampal atrophy in brains of aged APP/PS1 mice. Brain Res 1181: 93-103, 2007.
8. Yoo BC, Kim SH, Cairns N, Fountoulakis M and Lubec G: Deranged expression of molecular chaperones in brains of patients with Alzheimer's disease. Biochem Biophys Res Commun 280: 249-258, 2001.
9. Cole SL, Grudzien A, Manhart IO, Kelly BL, Oakley H and Vassar R: Statins cause intracellular accumulation of amyloid precursor protein, beta-secretase-cleaved fragments, and amyloid beta-peptide via an isoprenoid-dependent mechanism. J Biol Chem 280: 18755-18770, 2005.
10. Watson GS and Craft S: Modulation of memory by insulin and glucose: neuropsychological observations in Alzheimer's disease. Eur J Pharmacol 490: 97-113, 2004.
11. Franklin CA and Karkeck J: Weight loss in Alzheimer's disease: an international review of the literature. Int Psychogeriatr 6: 135-142, 1989.
12. Tamura BK, Masaki KH and Blanchette P: Weight loss in patients with Alzheimer's disease. J Nutr Elder 26: 21-38, 2007.
13. Cho JY, Hwang DY, Kang TS, Shin DH, Hwang JH, Lim CH, Lee SH, Lim HJ, Min SH, Seo SJ, Song YS, Nam KT, Lee KS, Cho JS, and Kim YK: Use of NSE/ PS2m-transgenic mice in the study of the protective effect of exercise on Alzheimer's disease. J Sports Sci 21: 943-951, 2003.
14. Cotman CW, Berchtold NC and Christie LA: Exercise builds brain health: key roles of growth factor cascades and inflammation. Trends Neurosci 30: 464-472, 2007.
15. Colcombe SJ, Kramer AF, Erickson KI, Scalf P, McAuley E, Cohen NJ, Webb A, Jerome GJ, Marquez DX and Elavsky S: Cardiovascular fitness, cortical plasticity, and aging. Proc Natl Acad Sci USA 101: 3316-3321, 2004.
16. Um HS, Kang EB, Leem YH, Cho IH, Yang CH, Chae KR, Hwang DY and Cho JY: Exercise training acts as a therapeutic strategy for reduction of the pathogenic phenotypes for Alzheimer's disease in an NSE/APPsw-transgenic model. Int J Mol Med 22: 529-539, 2008.
17. Packer L, Witt EH and Tritschler HJ: Alpha-lipoic acid as a biological antioxidant. Free Radic Biol Med 19: 227-250, 1995.
18. Konrad D, Somwar R, Sweeney G, Yaworsky K, Hayashi M, Ramlal T and Klip A: The antihyperglycemic drug alpha-lipoic acid stimulates glucose uptake via both GLUT4 translocation and GLUT4 activation: potential role of p38 mitogen-activated protein kinase in GLUT4 activation. Diabetes 50: 1464-1471, 2001.
19. Farr SA, Poon HF, Dogrukol-Ak D, Drake J and Banks WA, Eyerman E, Butterfield DA and Morley JE: The antioxidants alpha-lipoic acid and N-acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice. J Neurochem 84: 1173-1183, 2003.
20. Liu J, Head E, Gharib AM, Yuan W, Ingersoll RT, Hagen TM, Cotman CW and Ames BN: Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation: partial reversal by feeding acetyl-L-carnitine and/or R-alpha-lipoic acid. Proc Natl Acad Sci USA 99: 2356-2361, 2002.
21. Lovell MA, Xie C, Xiong S and Markesbery WR: Protection against amyloid beta peptide and iron/hydrogen peroxide toxicity by alpha lipoic acid. J Alzheimers Dis 5: 229-239, 2003.
22. Loske C, Neumann A, Cunningham AM, Nichol K, Schinzel R, Riederer P and Münch G: Cytotoxicity of advanced glycation endproducts is mediated by oxidative stress. J Neural Transm 105: 1005-1015, 1998.
23. Hwang DY, Cho JS, Lee SH, Chae KR, Lim HJ, Min SH, Seo SJ, Song YS, Song CW, Paik SG, Sheen YY and Kim YK: Aberrant expressions of pathogenic phenotype in Alzheimer's diseased transgenic mice carrying NSE-controlled APPsw. Exp Neurol 186: 20-32, 2004.
24. Bitar MS, Wahid S, Pilcher CW, Al-Saleh and Al-Mulla F: Alpha-lipoic acid mitigates insulin resistance in Goto-Kakizaki rats. Horm Metab Res 36: 542-549, 2004.
25. Morris RG, Garrud P, Rawlins JN and O'Keefe J: Place navigation impaired in rats with hippocampal lesions. Nature 297: 681-683, 1982.
26. Qutub AA and Hunt CA: Glucose transport to the brain: a systems model. Brain Res Rev 49: 595-617, 2005.
27. Simpson IA, Chundu KR, Davies-Hill T, Honer WG and Davies, P: Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease. Ann Neurol 5: 511-521, 1994.
28. Gervais FG, Xu D, Robertson GS, Vaillancourt JP, Zhu Y, Huang J, LeBlanc A, Smith D, Rigby M, Shearman MS, Clarke EE, Zheng H, Van Der Ploeg LH, Ruffolo SC, Thornberry NA, Xanthoudakis S, Zamboni RJ, Roy S and Nicholson DW: Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation. Cell 97: 395-406, 1999.
29. Noor R, Mittal S and Iqbal J: Superoxide dismutase - applications and relevance to human diseases. Med Sci Monit 8: 210-215, 2002.
30. Warrick JM, Chan HY, Gray-Board GL, Chai Y, Paulson HL and Bonini NM: Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70. Nat Genet 23: 425-428, 1999.
31. Yenari MA, Liu J, Zheng Z, Vexler ZS, Lee JE and Giffard RG: Antiapoptotic and anti-inflammatory mechanisms of heat-shock protein protection. Ann NY Acad Sci 1053: 74-83, 2005.
32. Nelson TJ and Alkon DL: Insulin and cholesterol pathways in neuronal function, memory and neurodegeneration. Biochem Soc Trans 33: 1033-1036, 2005.
33. Vance DE, Wadley VG, Ball KK, Roenker DL and Rizzo M: The effects of physical activity and sedentary behavior on cognitive health in older adults. J Aging Phys Act 13: 294-313, 2005.
34. Lytle ME, Vander BJ, Pandav RS, Dodge HH and Ganguli M: Exercise level and cognitive decline: the MoVIES project. Alzheimer Dis Assoc Disord 18: 57-64, 2004.
35. Cremer DR, Rabeler R, Roberts A and Lynch B: Long-term safety of alpha-lipoic acid (ALA) consumption: A 2-year study. Regul Toxicol Pharmacol 46: 193-201, 2006.
36. Lazarov O, Robinson J, Tang YP, Hairston IS, Korade-Mirnics Z, Lee VM, Hersh LB, Sapolsky RM, Mirnics K and Sisodia SS: Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice. Cell 120: 7011-7020, 2005.
37. Quinn JF, Bussiere JR, Hammond RS, Montine TJ, Henson E, Jones RE and Stackman RW Jr: Chronic dietary alpha-lipoic acid reduces deficits in hippocampal memory of aged Tg2576 mice. Neurobiol Aging 28: 213-225, 2007.
38. Horwood N and Davies DC: Immunolabelling of hippocampal microvessel glucose transporter protein is reduced in Alzheimer's disease. Virchows Arch 425: 69-72, 1994.
39. Schultheiss C, Blechert B, Gaertner FC, Drecoll E, Mueller J, Weber GF, Drzezga A and Essler M: In vivo characterization of endothelial cell activation in a transgenic mouse model of Alzheimer's disease. Angiogenesis 9: 59-65, 2006.
40. Mattson MP and Magnus T: Ageing and neuronal vulnerability. Nat Rev Neurosci 7: 278-294, 2006.
41. Cechetti F, Rhod A, Simao F, Santin K, Salbego C, Netto CA and Siqueira IR: Effect of treadmill exercise on cell damage in rat hippocampal slices submitted to oxygen and glucose deprivation. Brain Res 1157: 121-125, 2007.
42. Cui X, Zuo P, Zhang Q, Li X, Hu Y, Long J, Packer L and Liu J: Chronic systemic D-galactose exposure induces memory loss, neurodegeneration, and oxidative damage in mice: protective effects of R-alpha-lipoic acid. J Neurosci Res 84: 647-654, 2006.
43. Craft SS, Asthana DG, Cook D, Baker M, Cherrier K, Purganan C, Wait A, Petrova S, Latendresse GS, Watson JW, Newcomer GD, Schellenberg and Krohn AJ: Insulin dose-response effects on memory and plasma amyloid precursor protein in Alzheimer's disease: interactions with apolipoprotein E genotype. Psychoneuroendocrinology 28: 809-822, 2003.
44. Nichol KE, Parachikova AI and Cotman CW: Three weeks of running wheel exposure improves cognitive performance in the aged Tg2576 mouse. Behav Brain Res 184: 124-132, 2007.
45. Jesudason EP, Masilamoni JG, Jebaraj CE, Paul SF and Jayakumar R: Efficacy of DL-alpha lipoic acid against systemic inflammation-induced mice: antioxidant defense system. Mol Cell Biochem 313: 113-123, 2008.
46. Muchowski PJ, Schaffar G, Sittler A, Wanker EE, Hayer-Hartl MK and Hartl FU: Hsp70 and hsp40 chaperones can inhibit selfassembly of polyglutamine proteins into amyloid-like fibrils. Proc Natl Acad Sci USA 97: 7841-7846, 2000.
47. Campisi J, Leem TH, Greenwood BN, Hansen MK, Moraska A, Higgins K, Smith TP and Fleshner M: Habitual physical activity facilitates stress-induced HSP72 induction in brain, peripheral, and immune tissues. Am J Physiol Regul Integr Comp Physiol 284: R520-R530, 2003.
48. Kinnunen S, Hyyppä S, Oksala N, Laaksonen DE, Hannila ML, Sen CK and Atala M: Alpha-lipoic acid supplementation enhances heat shock protein production and decreases post exercise lactic acid concentrations in exercised standard bred trotters. Free Radic Res 22: 1-9, 2009.
49. Sparks DL, Petanceska S, Sabbagh M, Connor D, Soares H, Adler C, Lopez J, Ziolkowski C, Lochhead J and Browne P: Cholesterol, copper and Abeta in controls, MCI, AD and the AD Cholesterol-Lowering Treatment Trial (ADCLT). Curr Alzheimer Res 2: 495-506, 2005.
50. De la Monte SM and Wands JR: Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease. J Alzheimer Dis 7: 45-61, 2005.